NDC 63304-636

GANCICLOVIR

Ganciclovir

GANCICLOVIR is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Ranbaxy Pharmaceuticals Inc.. The primary component is Ganciclovir.

• Product ID: 63304-636_3406db8a-5ae9-4120-94bd-036701adbeca
• NDC: 63304-636
• Product Type: Human Prescription Drug
• Proprietary Name: GANCICLOVIR
• Generic Name: Ganciclovir
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2003-08-27
• Marketing Category: ANDA / ANDA
• Application Number: ANDA076457
• Labeler Name: Ranbaxy Pharmaceuticals Inc.
• Substance Name: GANCICLOVIR
• Active Ingredient Strength: 250 mg/1
• Pharm Classes: Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 63304-636-90

90 CAPSULE in 1 BOTTLE (63304-636-90)

• Marketing Start Date: 2003-08-27
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63304-636-90 [63304063690]

GANCICLOVIR CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA076457
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2003-08-27
• Inactivation Date: 2019-11-13

NDC 63304-636-10 [63304063610]

GANCICLOVIR CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA076457
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2003-08-27
• Inactivation Date: 2019-11-13

NDC 63304-636-60 [63304063660]

GANCICLOVIR CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA076457
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2003-08-27
• Inactivation Date: 2019-11-13

NDC 63304-636-28 [63304063628]

GANCICLOVIR CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA076457
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-08-27
• Inactivation Date: 2019-11-13

Drug Details

Active Ingredients

Ingredient	Strength
GANCICLOVIR	250 mg/1

OpenFDA Data

• SPL SET ID: 3406db8a-5ae9-4120-94bd-036701adbeca
• Manufacturer:
  • Ranbaxy Pharmaceuticals Inc.
• UNII:
  • P9G3CKZ4P5
• RxNorm Concept Unique ID - RxCUI:
  • 200206
  • 314007
• UPC Code:
  • 0363304637908

Pharmacological Class

• Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
• DNA Polymerase Inhibitors [MoA]
• Nucleoside Analog [EXT]
• Nucleoside Analog Antiviral [EPC]

NDC Crossover Matching brand name "GANCICLOVIR" or generic name "Ganciclovir"

NDC	Brand Name	Generic Name
0143-9299	Ganciclovir	Ganciclovir sodium
14335-030	Ganciclovir	ganciclovir sodium
24201-500	Ganciclovir	Ganciclovir
25021-185	ganciclovir	ganciclovir sodium
42023-173	Ganciclovir	Ganciclovir
51754-2500	GANCICLOVIR	GANCICLOVIR
51817-171	Ganciclovir	ganciclovir sodium
63304-636	GANCICLOVIR	GANCICLOVIR
63304-637	GANCICLOVIR	GANCICLOVIR
63323-315	Ganciclovir	GANCICLOVIR SODIUM
70436-089	Ganciclovir	ganciclovir sodium
76233-072	Ganciclovir	Ganciclovir Sodium
24208-535	ZIRGAN	ganciclovir